Alfresa Holdings Corporation
OTC: ALFRY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Ryuji Arakawa
- Employees
- 12,517
- Headquarters
- Tokyo, Japan
- IPO year
- 2018
- Market cap
- $2.5B
- Website
- https://www.alfresa.com
Loading ALFRY…
Loading profile data…Frequently asked questions about ALFRY
What does Alfresa Holdings Corporation (ALFRY) do?
Tokyo, Japan-based Alfresa Holdings Corporation, established in 2003, is a diversified entity operating domestically and internationally within the healthcare industry. The company's core activities encompass the production, wholesale distribution, marketing, and global trade of pharmaceuticals, diagnostic agents, and medical equipment. Alfresa...
Where does ALFRY trade?
Alfresa Holdings Corporation (ALFRY) trades on the Other OTC.
What sector is ALFRY in?
Alfresa Holdings Corporation (ALFRY) operates in the Healthcare sector, specifically in the Medical - Distribution industry.
Who is the CEO of Alfresa Holdings Corporation?
Ryuji Arakawa is the chief executive officer of Alfresa Holdings Corporation (ALFRY).
Where is Alfresa Holdings Corporation headquartered?
Alfresa Holdings Corporation is headquartered in Japan.
Does ALFRY pay a dividend?
Yes — Alfresa Holdings Corporation (ALFRY) paid a trailing twelve-month dividend of USD 0.44 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ALFRY go public?
Alfresa Holdings Corporation (ALFRY) completed its initial public offering in 2018.
Is ALFRY an ADR?
Yes — ALFRY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Alfresa Holdings Corporation reporting and dividends follow the underlying issuer.